Related Experiment Video

Updated: Jun 12, 2025

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training
09:15

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training

Published on: February 10, 2022

3.4K

Challenges and Priorities for Children With Congenital Valvar Heart Disease: The Heart Valve Collaboratory

Holly Bauser-Heaton1, Oliver M Barry2, Sophie C Hofferberth3

  • 1Department of Pediatric Cardiology, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA.

JACC. Advances
|September 18, 2024
PubMed

Insights

The Heart Valve Collaboratory convened experts to address unmet needs in pediatric and congenital heart valve disease. This workshop focused on current valve therapy and future development for improved patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering
  • Pediatric Cardiology

Background:

  • Heart valve disease affects patients of all ages, with unique challenges in pediatric and congenital cases.
  • The Heart Valve Collaboratory unites diverse stakeholders to tackle complex issues in heart valve disease.
  • Innovation is crucial for improving health outcomes for individuals with heart valve conditions.

Purpose of the Study:

  • To identify and address the unmet clinical needs of patients with pediatric and congenital heart valve disease.
  • To summarize the current state of heart valve therapy.
  • To outline the requirements for future heart valve development.

Main Methods:

  • A workshop was convened in October 2022 by the Scientific Council of the Heart Valve Collaboratory.
  • Experts from various stakeholder groups, including clinicians and regulatory bodies, participated.
  • Discussions focused on current challenges and future directions in pediatric and congenital heart valve disease.

Main Results:

  • Key unmet needs in pediatric and congenital heart valve disease were identified.
  • The current landscape of valve therapy was reviewed and summarized.
  • Critical areas for future valve development were highlighted.

Conclusions:

  • Addressing the specific needs of pediatric and congenital heart valve disease patients requires focused innovation.
  • Collaboration among cardiologists, surgeons, regulatory agencies, and industry is essential for advancing valve technology.
  • Future research and development should prioritize patient-centered solutions for congenital and acquired heart valve conditions.

Keywords:
collaboration in valve treatmentcongenital valve diseasetranscatheter valve therapy

More Related Videos

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents06:33

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents

Published on: September 21, 2021

2.3K
Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.6K

Related Concept Videos

Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
4.4K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
145
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
899
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
150
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K